Skip to content

Application of fibronectin in the treatment of oral ulce

Application of fibronectin in the treatment of oral ulce

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025430
Enrollment
Unknown
Registered
2019-08-26
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mouth ulcers

Interventions

test group: Fibronectin Freeze-dried Powder Fil

Sponsors

Liuzhou Maternal and Child Health Hospita
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Having the ability to sign the informed consent form; 2. Aged 18 to 60 years, male and female; 3. Ulcer attack time is not more than 48 hours; 4. Pain discrimination; 5. There were no more than 2 ulcers, and the ulcer diameter was not more than 5mm. 6. In line with the western medicine of oral ulcer diagnosis;

Exclusion criteria

Exclusion criteria: 1. Severe recurrent aphthous stomatitis, Behcet's disease; 2. There are systemic diseases background: anemia, malignant tumor, peptic ulcer, Crohn's disease, acute infectious diseases, autoimmune diseases, etc.; 3. Other drugs have been used; 4. Lactating woman or pregnant woman; 5. Allergic to many kinds of drugs; 6. Participated in other drug clinical trials within 3 months; 7. Severe tooth wear.

Design outcomes

Primary

MeasureTime frame
Ulcer pain VAS;Pain disappear time;The ulcer healing time;

Countries

China

Contacts

Public ContactLv Xiaolan

Laboratory Department, Liuzhou Maternal and Child Health Hospital

13505525@qq.com+86 15577727711

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026